SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio (IBRX) is trending with high community anticipation for upcoming ASCO GU data on its ANKTIVA immunotherapy. Many expect this data to solidify the drug's position as a standard-of-care backbone for various cancers, driving strong conviction and 'buy the dip' sentiment despite persistent short pressure.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA is intensely trending ahead of its upcoming earnings report, with widespread anticipation for another strong performance driven by insatiable demand for its AI chips and innovations. However, community discussion is sharply divided on whether robust results will overcome concerns about past 'sell the news' patterns and options volatility.

Circle Internet Group, Inc. is a financial technology company that enables businesses of all sizes to harness the power of digital currencies and public blockchains for payments, commerce and financial applications worldwide. The company was founded by Jeremy J. Allaire and Patrick Sean Neville in August 2013 and is headquartered in New York, NY.

Circle Internet Group Inc. - Ordinary Shares - Class A

Circle

Circle (CRCL) is trending after reporting strong quarterly earnings that surpassed expectations, showcasing robust growth in USDC adoption and transaction volume, which has ignited bullish sentiment and discussions around its pivotal role as foundational digital dollar infrastructure amid debates on its valuation and market sensitivity.

Larimar Therapeutics, Inc. Is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of novel therapeutics mitochondrial disorders and Friedreich's ataxia. The company was founded in 2005 and is headquartered in Bala Cynwyd, PA.

Larimar Therapeutics Inc

Larimar Therapeutics is drawing significant attention after its Friedreich's ataxia drug, nomlabofusp, received FDA Breakthrough Therapy Designation, fueling bullish price target increases and active community discussion on its potential as a blockbuster, even with ongoing debate about managing side effects.

Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. It focuses on building platforms for oncology, neuropsychiatry, cardiology, infectious disease, and radiology. The company was founded by Eric Paul Lefkofsky in August 2015 and is headquartered in Chicago, IL.

Tempus AI Inc. - Ordinary Shares - Class A

Tempus AI Inc

Tempus AI is trending following strong preliminary Q4 and full-year revenue results, a record total contract value driven by expanding pharma partnerships, and new collaborations in genomic testing. The community is bullish, citing a new $100 price target from Mizuho and institutional interest, though some debate lingers about future growth guidance and profitability.

Intuitive Machines, Inc. is a space exploration, infrastructure, and services company, which engages in contributing to the establishment of cislunar infrastructure and helping to develop cislunar and deep space commerce. It offers space products and services. The company was founded by Stephen J. Altemus, Kam Ghaffarian, and Timothy P. Crain in 2013 and is headquartered in Houston, TX.

Intuitive Machines Inc - Ordinary Shares - Class A

Intuitive Machines Inc

Intuitive Machines (LUNR) is highly discussed after an announced $175 million private equity placement caused a share price drop. Many in the community are debating whether the market's reaction to the dilution is an overcorrection, particularly as the funds are earmarked for strategic growth in space infrastructure and lunar services, including potential NASA contracts like the Lunar Terrain Vehicle award.

Oddity Tech Ltd. engages in the online retail sale of cosmetics and beauty products. Its products include lipsticks, makeup brushes, mascara, eyelash curlers, and makeup brush cleansers. The company was founded by Oran Holtzman and Shiran Holtzman-Erel on March 23, 2013 and is headquartered in Tel Aviv, Israel.

ODDITY Tech Ltd. - Ordinary Shares - Class A

ODDITY Tech Ltd. is trending after a dramatic share price fall, driven by a forecast of substantial revenue decline in the upcoming quarter due to an advertising algorithm issue, as the community intensely debates if the sell-off is an overreaction or signals deeper concerns about the company's operational integrity.

Bloom Energy Corp. engages in the manufacture and installation of a solid oxide fuel-cell based power generation platform. Its product, Bloom Energy Server, converts standard low-pressure natural gas or biogas into electricity through an electrochemical process without combustion. The company was founded by K. R. Sridhar, John Finn, Jim McElroy, Matthias Gottmann, and Dien Nguyen on January 18, 2001, and is headquartered in San Jose, CA.

Bloom Energy Corp - Ordinary Shares - Class A

Bloom Energy Corp

Bloom Energy is trending due to outstanding Q4 earnings and highly optimistic 2026 revenue guidance, driven by surging demand for its fuel cell technology from energy-intensive AI data centers. The community is actively discussing its massive product backlog and potential for new all-time highs, despite some caution around its current high valuation and options-driven volatility.

Cava Group, Inc. is a holding company, which engages in the category-defining Mediterranean fast-casual restaurant brand, bringing together healthful food and bold, satisfying flavors at scale. It operates through the following segments: CAVA and CAVA Foods. The CAVA segment includes the operations of all company-owned CAVA restaurants. The CAVA Foods segment includes the production of dips and spreads used in CAVA restaurants as well as sales from the consumer-packaged goods (CPG) business. The company was founded by Brett Schulman, Ike Grigoropoulus, Dimitri Moshovitis, and Theodore Xenohristos in 2010 and is headquartered in Washington, DC.

Cava Group Inc

CAVA Group Inc

CAVA Group is trending following strong Q4 earnings that surpassed analyst expectations, fueled by double-digit revenue growth and upbeat FY26 guidance for restaurant expansion and same-store sales. The market is buzzing with a perceived short squeeze, as bulls celebrate the upward momentum and increased price targets, while some express skepticism over the stock's high valuation despite its growth in the fast-casual dining sector.

Axon Enterprise, Inc. engages in the development, manufacture, and sale of conducted electrical weapons for personal defense. It operates through the TASER segment and Software and Sensors segment. The TASER segment sells conducted electrical weapons, accessories, and other related products and services. The Software and Sensors segment includes devices, wearables, applications, cloud, and mobile products. The company was founded by Patrick W. Smith and Thomas P. Smith on September 7, 1993 and is headquartered in Scottsdale, AZ.

Axon Enterprise Inc

Axon Enterprise is trending due to strong financial results and an upbeat multi-year outlook, particularly highlighting its expanding AI-powered public safety ecosystem. The community is actively discussing a significant short squeeze, seeing the company's hardware-software integration and market dominance as a key long-term growth story.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

FDA Approves Sanofi And Regeneron's Dupixent As First Medicine For Allergic Fungal Rhinosinusitis

(RTTNews) - Sanofi (SNY, SAN.PA) said FDA has approved Dupixent or dupilumab for the treatment of adult and pediatric patients aged 6 years and older with allergic fungal rhinosinusitis who have a...

BMRN Beats on Q4 Earnings, to Withdraw Roctavian From Market

BioMarin beats Q4 earnings estimates as Voxzogo drives year-over-year revenue growth. The company decides to voluntarily withdraw its hemophilia gene therapy.

IOVA vs. RIGL: Which Small-Cap Biotech Has More Upside Potential?

With Amtagvi sales surging but shares down 46%, can Iovance's growth runway outshine Rigel's strong 2025 rally?

Kraig Biocraft Laboratories Featured on the Cover of National Geographic

Kraig Biocraft Laboratories (OTCQB: KBLB) groundbreaking work in commercializing spider silk is featured on the cover of the March 2026 issue of National Geographic magazine.

Sanofi $SNY Shares Purchased by NewEdge Wealth LLC

NewEdge Wealth LLC boosted its holdings in Sanofi (NASDAQ:SNY - Free Report) by 63.1% during the 3rd quarter, according to its most recent disclosure with the SEC. The firm owned 67,303 shares of the...

Sanofi (NASDAQ:SNY) Cut to "Buy" at Wall Street Zen

Wall Street Zen downgraded Sanofi from a "strong-buy" rating to a "buy" rating in a research report on Saturday...

Moderna Stock Jumps After FDA Reverses Course on Flu Shot

MRNA stock rises 6% as the FDA agrees to review its flu vaccine filing after a surprise reversal, with a decision expected by Aug. 5, 2026.

Sanofi $SNY Shares Acquired by Aberdeen Group plc

Aberdeen Group plc increased its stake in shares of Sanofi (NASDAQ:SNY - Free Report) by 17.7% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission...

It’s Not Synthetic, It’s Real. Kraig Labs Nears Spider Silk Breakthrough

Kraig Biocraft Laboratories (OTCQB:KBLB), the undisputed global leader in the development and commercialization of spider silk, is entering what may prove to be the defining phase of its multi-decade development arc, as the company accelerates toward commercial-scale production of biodegradable spider silk derived from transgenic silkworms

Will Tavalisse Continue to Drive Rigel Pharmaceuticals' Growth in 2026?

RIGL's 2025 sales jump 60% to $232M, led by Tavalisse. With 2026 product sales seen at $255-$265M, can its momentum withstand rising competition?

Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the Biopharma segment, which comprises commercial operations and research, development and production activities relating to the specialty care, general medicines and vaccines franchises plus support and corporate functions, for all geographical territories. The company was founded in 1973 and is headquartered in Paris, France.

Sanofi - ADR

Beat EPS and revenue

Beat EPS, miss revenue

Miss EPS, beat revenue

Miss EPS and revenue

Ahead of earnings, sentiment is split between blowout AI growth and concerns around macro pressure, positioning, and post-ER volatility. How do you see it playing out?

Fiscal Period	Estimated	Reported	Surprise	Result
Q1 '26	$1.05	--	--	N/A
Q4 '25	$0.84	$0.91	8.38%	BEAT
Q3 '25	$1.58	$1.69	7.23%	BEAT
Q2 '25	$0.96	$0.91	-5.11%	MISSED
Q1 '25	$0.93	$0.78	-15.53%	MISSED

SNY
Sanofi-Aventis

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q4 '25

Historical Earnings

Latest SNY News

SNYSanofi-Aventis